ATHEROGENICS INC
S-1/A, EX-23.01, 2000-08-04
PHARMACEUTICAL PREPARATIONS
Previous: ATHEROGENICS INC, S-1/A, EX-10.02, 2000-08-04
Next: ATHEROGENICS INC, S-1/A, EX-27.1, 2000-08-04



<PAGE>   1
                                                                   EXHIBIT 23.01

                        CONSENT OF INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" and to the
use of our report dated February 18, 2000, in Amendment No. 4 to the
Registration Statement (Form S-1 No. 333-31140) and related Prospectus of
AtheroGenics, Inc. for the Registration of 6,000,000 shares of its common stock.


                                                 /s/ Ernst & Young LLP



Atlanta, Georgia
August 4, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission